Therefore, TFPI2 produced by the syncytiotrophoblasts would provide antifibrinolytic activity and stabilize clotting factors during pregnancy and delivery to maintain a hypercoagulable state and inhibit bleeding. The gene discussed is TFPI2; the disease is thrombophilia.